Global and United States Monoclonal Antibody Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Humanized Antibody
1.2.3 Human Mouse Chimeric Antibody
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2015-2026)
2.2 Global Monoclonal Antibody Therapeutics Growth Trends by Regions
2.2.1 Monoclonal Antibody Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Monoclonal Antibody Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Therapeutics Players by Market Size
3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2019
3.5 Key Players Monoclonal Antibody Therapeutics Area Served
3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2021-2026)
5 Monoclonal Antibody Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Monoclonal Antibody Therapeutics Market Size (2015-2026)
6.2 North America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
6.3 North America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
6.4 North America Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Monoclonal Antibody Therapeutics Market Size (2015-2026)
7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Monoclonal Antibody Therapeutics Market Size (2015-2026)
8.2 China Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
8.3 China Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
8.4 China Monoclonal Antibody Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Monoclonal Antibody Therapeutics Market Size (2015-2026)
9.2 Japan Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
9.3 Japan Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
9.4 Japan Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020))
11.1.5 Bayer Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Monoclonal Antibody Therapeutics Introduction
11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.6.5 Merck Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.8.5 AbbVie Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.9.5 Amgen Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
11.10.5 Johnson & Johnson Recent Development
11.11 Bristol-Myers Squibb Company
10.11.1 Bristol-Myers Squibb Company Company Details
10.11.2 Bristol-Myers Squibb Company Business Overview
10.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
10.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
10.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Biogen
10.12.1 Biogen Company Details
10.12.2 Biogen Business Overview
10.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
10.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
10.12.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Humanized Antibody
Table 4. Key Players of Human Mouse Chimeric Antibody
Table 5. Global Monoclonal Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Monoclonal Antibody Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Monoclonal Antibody Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Monoclonal Antibody Therapeutics Market Share by Regions (2015-2020)
Table 9. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Monoclonal Antibody Therapeutics Market Share by Regions (2021-2026)
Table 11. Monoclonal Antibody Therapeutics Market Market Trends
Table 12. Monoclonal Antibody Therapeutics Market Drivers
Table 13. Monoclonal Antibody Therapeutics Market Challenges
Table 14. Monoclonal Antibody Therapeutics Market Restraints
Table 15. Global Monoclonal Antibody Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Monoclonal Antibody Therapeutics Market Share by Players (2015-2020)
Table 17. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2019)
Table 18. Global Monoclonal Antibody Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Monoclonal Antibody Therapeutics Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Monoclonal Antibody Therapeutics Market Size Share by Type (2015-2020)
Table 24. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2021-2026)
Table 25. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2015-2020)
Table 26. Global Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Monoclonal Antibody Therapeutics Market Size Share by Application (2021-2026)
Table 28. North America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 30. North America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 32. North America Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Monoclonal Antibody Therapeutics Market Share by Country (2015-2020)
Table 34. Europe Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 36. Europe Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Monoclonal Antibody Therapeutics Market Share by Country (2015-2020)
Table 40. China Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 41. China Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 42. China Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 43. China Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 44. China Monoclonal Antibody Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 45. China Monoclonal Antibody Therapeutics Market Share by Region (2015-2020)
Table 46. Japan Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 48. Japan Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Monoclonal Antibody Therapeutics Market Share by Country (2015-2020)
Table 52. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Type (2015-2020)
Table 54. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Monoclonal Antibody Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Monoclonal Antibody Therapeutics Market Share by Country (2015-2020)
Table 58. Bayer Company Details
Table 59. Bayer Business Overview
Table 60. Bayer Product
Table 61. Bayer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 62. Bayer Recent Development
Table 63. F. Hoffmann-La Roche Company Details
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Product
Table 66. F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Product
Table 71. Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Product
Table 76. Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 77. Sanofi Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Product
Table 81. GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Product
Table 86. Merck Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 87. Merck Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Product
Table 91. Novartis Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 92. Novartis Recent Development
Table 93. AbbVie Business Overview
Table 94. AbbVie Product
Table 95. AbbVie Company Details
Table 96. AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 97. AbbVie Recent Development
Table 98. Amgen Company Details
Table 99. Amgen Business Overview
Table 100. Amgen Product
Table 101. Amgen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 102. Amgen Recent Development
Table 103. Johnson & Johnson Company Details
Table 104. Johnson & Johnson Business Overview
Table 105. Johnson & Johnson Product
Table 106. Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 107. Johnson & Johnson Recent Development
Table 108. Bristol-Myers Squibb Company Company Details
Table 109. Bristol-Myers Squibb Company Business Overview
Table 110. Bristol-Myers Squibb Company Product
Table 111. Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 112. Bristol-Myers Squibb Company Recent Development
Table 113. Biogen Company Details
Table 114. Biogen Business Overview
Table 115. Biogen Product
Table 116. Biogen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020) (US$ Million)
Table 117. Biogen Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Monoclonal Antibody Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Humanized Antibody Features
Figure 3. Human Mouse Chimeric Antibody Features
Figure 4. Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Cancer Case Studies
Figure 6. Autoimmune Diseases Case Studies
Figure 7. Infection Case Studies
Figure 8. Hematological Diseases Case Studies
Figure 9. Ophthalmological Diseases Case Studies
Figure 10. Others Case Studies
Figure 11. Monoclonal Antibody Therapeutics Report Years Considered
Figure 12. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Monoclonal Antibody Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Monoclonal Antibody Therapeutics Market Share by Regions (2021-2026)
Figure 15. Global Monoclonal Antibody Therapeutics Market Share by Players in 2019
Figure 16. Global Top Monoclonal Antibody Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Monoclonal Antibody Therapeutics Revenue in 2019
Figure 18. North America Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Monoclonal Antibody Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Bayer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 47. Pfizer Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 48. Sanofi Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 50. Merck Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 51. Novartis Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 52. AbbVie Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 53. Amgen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 54. Johnson & Johnson Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 56. Biogen Revenue Growth Rate in Monoclonal Antibody Therapeutics Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed